Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals

Journal of Human Hypertension

Volumn 27, Issue 9, 2013, Pages 545-551

  Chowdhury, E K ^a   Owen, A ^a   Krum, H ^a   Wing, L M H ^b   Ryan, P ^c   Nelson, M R ^d   Reid, C M ^a  

^a MONASH UNIVERSITY   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Australia; barriers; blood pressure; control; elderly

Indexed keywords

CREATININE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICATION COMPLIANCE; PROSPECTIVE STUDY; PULSE PRESSURE; RANDOMIZATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; BLOOD PRESSURE; DISEASE MANAGEMENT; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LIFE STYLE; LONGITUDINAL STUDIES; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 84882455081     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.11     Document Type: Article

References (35)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure?the JNC 7 Report. JAMA 2003; 289(19): 2560-2572.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2004; 365(9455): 217-223.
3. Australian Institute of Health and Welfare. Australia's health 2008. Cat. no. AUS 99AIHW: Canberra, Australia, 2008.
4. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355(9207): 865-872.
5. Fahey T, Schroeder K, Ebrahim S. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 20062Please provide the article no. in reference 5.
6. Afridi I, Canny J, Yao CH, Christensen B, Cooper RS, Kadiri S et al. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11): 1983-1992.
7. Mancia G, De Backer G, Dominiczak A, Fagard R, Germano G, Grassi G et al. 2007 ESH-ESC guidelines for the management of arterial hypertension -The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Blood Pressure 2007; 16(3): 135-232.
8. Reid C, Nelson MR, Shiel L, Chew D, Connor G, DeLooze F. Australians at risk: management of cardiovascular risk factors in the REACH registry. Heart Lung Circ 2008; 17(2): 114-118.
9. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290(2): 199-206.
10. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum. JAMA 2005; 294(4): 466-472.
11. Charpentier MM, Bundeff A. Treating hypertension in the very elderly. Ann Pharmacother 2011; 45(9): 1138-1143.
12. Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens 2008; 10(1): 20-26.
13. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162(4): 413-420.
14. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005; 112(11): 1651-1662.
15. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypert 2002; 4(6): 393-404.
16. Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348(7): 583-592.
17. Pink B. Australian Standard Geographical Classification (ASGC) July 2010. In: Australian Bureau of Statistics. pp 35-37, 2010, ABS Catalogue No. 1216.0.
18. Australian Bureau of Statistics. SEIFA: Socio-Economic Indexes for Areas. In. http://www.abs.gov.au/websitedbs/D3310114.nsf/home/SeifaentrypageAccessed 2011.
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive-validity of a selfreported measure of medication adherence. Med Care 1986; 24(1): 67-74.
20. Nelson MR, Reid CM, Ryan P, Willson K, Yelland L, Comm AM. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006; 185(9): 487-489.
21. Probstfield JL. Prevention of stroke by antihypertensive drug-treatment in older persons with isolated systolic hypertension -final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265(24): 3255-3264.
22. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350(9080): 757-764.
23. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH et al. Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertension 2001; 37(1): 12-18.
24. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older US Adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55(7): 1056-1065.
25. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women -the Framingham Heart Study. Hypertension 2004; 43(6): 1239-1245.
26. Izzo JL Jr, Shykoff BE. Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med 2001; 2(1): 29-3437-40.
27. Majernick TG, Zacker C, Madden NA, Belletti DA, Arcona S. Correlates of hypertension control in a primary care setting. Am J Hypertens 2004; 17(10): 915-920.
28. Hicks LS, Fairchild DG, Horng MS, Orav EJ, Bates DW, Ayanian JZ. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension 2004; 44(4): 429-434.
29. Van der Niepen P, Dupont AG. Improved blood pressure control in elderly hypertensive patients results of the PAPY-65 survey. Drugs Aging 2010; 27(7): 573-588.
30. Roux O, Chapellier M, Czernichow S, Nisse-Durgeat S, Safar ME, Blacher J. Determinants of hypertension control in a large French population of treated hypertensive subjects. Blood Pressure 2006; 15(1): 6-13.
31. Brindel P, Hanon O, Dartigues JF, Ritchie K, Lacombe JM, Ducimetiere P et al. Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens 2006; 24(1): 51-58.
32. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 2008; 51(4): 1149-1155.
33. Australian Institute of Health and Welfare. Rural, Regional and Remote Health: Indicators of Health System Performance. Cat. no. PHE 103AIHW: Canberra, Australia, 2008.
34. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339(27): 1957-1963.
35. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345(7): 479-486.